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Abstract
Background: The World Health Organization (WHO), like many other organisations around the world, has recognised the need
to use more rigorous processes to ensure that health care recommendations are informed by the best available research evidence.
This is the 14th of a series of 16 reviews that have been prepared as background for advice from the WHO Advisory Committee
on Health Research to WHO on how to achieve this.
Objectives: We reviewed the literature on reporting guidelines and recommendations.
Methods: We searched PubMed and three databases of methodological studies for existing systematic reviews and relevant
methodological research. We did not conduct systematic reviews ourselves. Our conclusions are based on the available evidence,
consideration of what WHO and other organisations are doing and logical arguments.
Key questions and answers: There is little empirical evidence that addresses these questions. Our answers are based on logical
arguments and standards put forward by other groups.
What standard types of recommendations or reports should WHO use?
• WHO should develop standard formats for reporting recommendations to facilitate recognition and use by decision makers for
whom the recommendations are intended, and to ensure that all the information needed to judge the quality of a guideline,
determine its applicability and, if needed, adapt it, is reported.
• WHO should develop standard formats for full systematically developed guidelines that are sponsored by WHO, rapid
assessments, and guidelines that are endorsed by WHO.
• All three formats should include the same information as full guidelines, indicating explicitly what the group preparing the
guideline did not do, as well as the methods that were used.
• These formats should be used across clinical, public health and health systems recommendations.
How should recommendations be formulated and reported?
• Reports should be structured, using headings that correspond to those suggested by the Conference on Guideline
Standardization or similar headings.
• The quality of evidence and strength of recommendations should be reported explicitly using a standard approach.
• The way in which recommendations are formulated should be adapted to the specific characteristics of a specific guideline.
• Urgent attention should be given to developing a template that provides decision makers with the relevant global evidence that 
is needed to inform a decision and offers practical methods for incorporating the context specific evidence and judgements that 
are needed.
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Background
The World Health Organization (WHO), like many other
organisations around the world, has recognised the need
to use more rigorous processes to ensure that health care
recommendations are informed by the best available
research evidence. This is the 14th of a series of 16 reviews
that have been prepared as background for advice from
the WHO Advisory Committee on Health Research to
WHO on how to achieve this.
Guidelines are formal advisory statements that should be
robust enough to meet the unique circumstances and con-
straints of the specific situation to which they are being
applied [1]. The basic nature and intent of guidelines have
been variously labelled as guidance, guides, guiding prin-
ciples, recommendations, policies, protocols, best prac-
tice, algorithms, consensus statements, expert committee
recommendations, integrated care pathways, manuals,
tool kits, handbooks, model lists, technical updates and
principles [1,2]. Whatever they are called, rigorously
developed guidelines, can translate complicated research
findings into actionable recommendations. They are an
important step in moving from research to action and
ensuring that the best available research evidence informs
decisions and actions [3]. However, for users of guidelines
to be able to apply criteria to assess whether guidelines
have been rigorously developed and are likely to be valid
and applicable [3-6], the information needed to make
these judgements must be reported [7]. Unfortunately,
critical information is often absent from published guide-
lines [5,7,8].
In this paper we address the following questions:
• What standard types of recommendations or reports
should WHO use?
• How should recommendations be formulated and
reported?
We address questions about reporting systematic reviews
[9] and dissemination [10] in other papers in this series.
What WHO is doing now
Although the Guidelines for WHO Guidelines recom-
mends "that a uniform, readily-recognizable printing for-
mat be developed for WHO guidelines," there are, as yet,
no standard formats for WHO policies, recommendations
or guidelines. A survey of WHO guidelines published in
2005 found that WHO publishes a large number of rec-
ommendations of many different types, in many different
formats [2], and a review of WHO documents did not find
any standards for reporting WHO recommendations [11].
What other organisations are doing
In a recent survey of organisations that produce clinical
practice guidelines, all 31 organisations that responded
(response rate 86%), and 46 of 57 (81%) of units that
support the use of research evidence by governments in
developing health policy, reported producing full versions
of guidelines with references and notes [12]. Several
organisations use different formats for different types of
recommendations, and a majority produce different ver-
sions of guidelines, such as executive summaries, summa-
ries of take-home messages, separate versions for different
target users, and tools for application (e.g., algorithms or
flow charts). Many guideline producers have standard for-
mats that they use and some organisations, such as the
U.S. National Guidelines Clearing House, have developed
standard formats for reporting guidelines produced by
other organisations [13].
The UK National Center for Health and Clinical Excel-
lence (NICE) states that recommendations should be clear
and concise, but should contain sufficient information
that they can be understood without reference to other
supporting material [14]. This is particularly important
where recommendations are published in isolation from
the background details in the full guideline. Any terminol-
ogy included in the recommendations therefore needs to
be clearly defined and unambiguous.
Methods
The methods used to prepare this review are described in
the introduction to this series [15]. Briefly, the key ques-
tions addressed in this paper were vetted amongst the
authors and the ACHR Subcommittee on the Use of
Research Evidence (SURE). We did not conduct a full sys-
tematic review. We searched PubMed and three databases
of methodological studies (the Cochrane Methodology
Register [16], the US National Guideline Clearinghouse
[17], and the Guidelines International Network [18]) for
existing systematic reviews and relevant methodological
research that address these questions. The answers to the
questions are our conclusions based on the available evi-
dence, consideration of what WHO and other organisa-
tions are doing, and logical arguments.
For this review we searched PubMed using [the MeSH
terms 'Documentation/standards' and 'Practice Guide-
lines/standards'] and related articles; the Cochrane Meth-
odology Register using [the key words 'CMR: Review
methodology – applicability & recommendations' and the
text words (format or reporting)] and ['Levels of evidence
and strength of recommendations']; the National Guide-
lines Clearinghouse annotated bibliography using the
terms format, reporting and structure; and checked the ref-
erence lists of retrieved articles.Health Research Policy and Systems 2006, 4:26 http://www.health-policy-systems.com/content/4/1/26
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Findings
What standard types of recommendations or reports 
should WHO use?
Given the wide variety of different types of recommenda-
tions that are made by WHO, there is likely to be a need
for several standard types of recommendations. Systemat-
ically developed clinical practice guidelines can take 18
months or more and as many as 15 meetings [19]. Sys-
tematically developed public health guidelines also
require substantial resources and time [20]. Given the
time and resources required to produce guidelines, many
organisations, particularly HTA organisations, have devel-
oped rapid assessment processes [21-25]. There is varia-
tion in the scope, methods, time to complete assessments,
and the formats used to report rapid assessments. Another
type of recommendation or guideline that is receiving
increasing attention, also because of the resources and
time required to develop guidelines systematically, are
guidelines developed by other organisations that have
been adapted or endorsed [26-28]. Another approach
being taken in several countries is to create databases or
clearinghouses of clinical practice guidelines with the aim
of facilitating their evaluation and adaptation for local use
by health care organizations [29].
Systematically developed clinical recommendations, pub-
lic health recommendations, and health systems recom-
mendations all require similar processes to ensure their
quality. Decision makers also require similar types of
information to be able to critically appraise whether
guidelines have been rigorously developed and are likely
to be valid [3,4,7,20,30,31].
How should recommendations be formulated and 
reported?
The Conference on Guideline Standardization (COGS)
used a two-stage modified Delphi process to develop
standards for reporting clinical practice guidelines [7].
Representatives of 22 organisations active in guideline
development reviewed the proposed items and com-
mented favourably. The items were consolidated into 18
topics (Table 1) to create the COGS checklist, which pro-
vides a framework to support comprehensive documenta-
tion of guidelines. While it is possible that some guideline
developers may not include content for every item, it is
suggested that they should address explicitly whether the
guideline development team considered that item.
While many organisations have their own standard for-
mats for reporting guidelines, this is the only consensus
standard for reporting guidelines across organisations. We
have, however, summarised the key items included in
guidelines for guidelines, which provides the basis for a
similar, but more comprehensive checklist for conducting
or reporting guidelines [32]. In addition, there are a
number of instruments for evaluating clinical practice
guidelines that can also be used as checklists for reporting
[1,4-6,33]. The content used in the National Guideline
Clearing house also represents a standard for reporting
imposed on organisations that want their guidelines
included in that database [13]. It includes 52 items under
the following headings: scope, methodology – including
rating scheme and cost analysis, recommendations, evi-
dence supporting the recommendations, benefits/harms
of implementing the recommendations, contraindica-
tions, qualifying statements, implementation of the
guideline, Institute of Medicine (IOM) national health-
care quality report categories, identifying information and
availability, and disclaimer; in addition to indexing
attributes.
Similarly, some journals have standard formats for report-
ing clinical practice guidelines, including structured
abstracts with the following headings [34]:
Objective
a succinct statement of the objective of the guideline,
including the targeted health problem, the targeted
patients and providers, and the main reason for develop-
ing recommendations concerning this problem for this
population.
Options
principal practice options that were considered in formu-
lating the guideline.
Outcomes
significant health and economic outcomes identified as
potential consequences of the practice options.
Evidence
methods used to gather, select, and synthesize evidence,
and the date of the most recent evidence obtained.
Values
persons and methods used to assign values (relative
importance) to potential outcomes of alternative practice
options.
Benefits, harms, and costs
the type and magnitude of the main benefits, harms, and
costs that are expected to result from guideline implemen-
tation.
Recommendations
a brief and specific list of key recommendations.Health Research Policy and Systems 2006, 4:26 http://www.health-policy-systems.com/content/4/1/26
Page 4 of 6
(page number not for citation purposes)
Validation
the results of any external review, comparison with guide-
lines developed by other groups, or clinical testing of
guideline use.
Sponsors
key persons or groups that developed, funded, or
endorsed the guideline.
While many organisations have standards for how recom-
mendations are formulated, we are not aware of any con-
sensus standards for how recommendations should be
formulated. Most guidelines development groups now
grade the quality of evidence and the strength of recom-
mendations, but a variety of different grading systems are
used [12,35].
Shekelle and colleagues evaluated the effect of different
levels of specificity of recommendations on clinicians test
ordering behaviour using clinical vignettes [36]. They
found that clinicians receiving the non-specific recom-
mendations ordered fewer indicated tests for appropriate
clinical vignettes than did physicians receiving specific
recommendations. Furthermore, compared to physicians
receiving non-specific guidelines, physicians receiving
specific guidelines ordered significantly more appropriate
tests for corresponding vignettes and significantly fewer
tests for inappropriate vignettes. The authors concluded
that the clarity and clinical applicability of a guideline
might be important attributes that contribute to the
effects of practice guidelines. We did not find any other
comparisons of different ways of formulating recommen-
dations, and it is likely that the way in which recommen-
Table 1: The COGS checklist for reporting clinical practice guidelines (from Shiffman et al. [7])*
Topic Description
1. Overview material Provide a structured abstract that includes the guideline's release date, status (original, revised, updated), 
and print and electronic sources.
2. Focus Describe the primary disease/condition and intervention/service/technology that the guideline addresses. 
Indicate any alternative preventive, diagnostic or therapeutic interventions that were considered during 
development.
3. Goal Describe the goal that following the guideline is expected to achieve, including the rationale for 
development of a guideline on this topic.
4. Users/setting Describe the intended users of the guideline (e.g., provider types, patients) and the settings in which the 
guideline is intended to be used.
5. Target population Describe the patient population eligible for guideline recommendations and list any exclusion criteria.
6. Developer Identify the organization(s) responsible for guideline development and the names/credentials/potential 
conflicts of interest of individuals involved in the guideline's development.
7. Funding sources/sponsor Identify the funding source/sponsor and describe its role in developing and/or reporting the guideline. 
Disclose potential conflict of interest.
8. Evidence collection Describe the methods used to search the scientific literature, including the range of dates and databases 
searched, and criteria applied to filter the retrieved evidence.
9. Recommendation grading criteria Describe the criteria used to rate the quality of evidence that supports the recommendations and the 
system for describing the strength of the recommendations. Recommendation strength communicates the 
importance of adherence to a recommendation and is based on both the quality of the evidence and the 
magnitude of anticipated benefits or harms.
10. Method for synthesizing evidence Describe how evidence was used to create recommendations, e.g., evidence tables, meta-analysis, decision 
analysis.
11. Prerelease review Describe how the guideline developer reviewed and/or tested the guidelines prior to release.
12. Update plan State whether or not there is a plan to update the guideline and, if applicable, an expiration date for this 
version of the guideline.
13. Definitions Define unfamiliar terms and those critical to correct application of the guideline that might be subject to 
misinterpretation.
14. Recommendations and rationale State the recommended action precisely and the specific circumstances under which to perform it. Justify 
each recommendation by describing the linkage between the recommendation and its supporting evidence. 
Indicate the quality of evidence and the recommendation strength, based on the criteria described in 9.
15. Potential benefits and harms Describe anticipated benefits and potential risks associated with implementation of guideline 
recommendations.
16. Patient preferences Describe the role of patient preferences when a recommendation involves a substantial element of personal 
choice or values.
17. Algorithm Provide (when appropriate) a graphical description of the stages and decisions in clinical care described by 
the guideline.
18. Implementation considerations Describe anticipated barriers to application of the recommendations. Provide reference to any auxiliary 
documents for providers or patients that are intended to facilitate implementation. Suggest review criteria 
for measuring changes in care when the guideline is implemented.
*COGS = Conference on Guideline Standardization.Health Research Policy and Systems 2006, 4:26 http://www.health-policy-systems.com/content/4/1/26
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dations are formulated may need to be adapted to the
specific characteristics of a guideline. However, there is a
consensus that recommended actions should be stated
precisely [7].
Both checklists for evaluating guidelines and for reporting
guidelines include items that may be dependent on the
specific setting in which a guideline is developed or used.
There are a number of international organisations, includ-
ing WHO, that develop guidelines that are intended to be
used in a variety of settings around the world. We did not
find any published papers that addressed methods for tak-
ing into account setting specific factors in international
guidelines, although several groups are working on meth-
ods for adapting guidelines developed in one setting for
use in another [27,28,37-39].
Discussion
While the content of WHO guidelines, recommendations
and policies will vary, depending on the topic, it would be
desirable to have standard formats across different topics
to facilitate recognition and use by decision makers and
ensure that all the information needed to judge the qual-
ity of a guideline, determine its applicability and, if
needed, adapt it is reported. There is likely a need for at
least three standard formats: full systematically developed
guidelines that are sponsored by WHO, rapid assess-
ments, and guidelines that are endorsed by WHO. Stand-
ards such as those advocated by COGS should form the
basis for developing a uniform format for full guidelines
developed by WHO. Although the COGS standards were
developed for clinical practice guidelines, the same con-
siderations are relevant to public health and health sys-
tems recommendations. Further consideration is needed
regarding the inclusion of additional items that need to be
considered in WHO guidelines, such as applicability to
different settings, equity, and scaling up. In particular,
work is needed to develop a template for decision-making
frameworks when different conditions are likely to lead to
different decisions in different settings [40,41]. In addi-
tion, different versions of guidelines should be developed
for different target audiences, including a structured exec-
utive summary and key messages [31,34].
A different format for rapid assessments would help to
distinguish these from full guidelines and could be
designed to reduce the work and time necessary to com-
plete a report. Rapid assessments should, nonetheless,
include the same information as full guidelines, indicat-
ing explicitly what the group preparing the guideline did
not do, as well as the methods that were used.
WHO has limited resources and capacity for developing
guidelines. At the same time, low and middle-income
(LMIC) countries also have limited resources and capac-
ity, and a core function of WHO is to provide its member
states, particularly LMIC, with technical advice that is
informed by the best available research evidence. Through
collaborating with other organisations and establishing
standards for reporting, and possibly endorsing guide-
lines developed by other organisations, WHO may be able
to expand its potential for supporting access to guidelines
that are appropriate for LMIC or can easily be adapted to
conditions in LMIC.
Given WHO's role as the world's leading public health
agency and its mandate to provide evidence-informed
guidance, it is of major importance for WHO to address
and develop methods for formulating and reporting rec-
ommendations that are developed internationally, but
need to be adapted and implemented in specific settings.
Further work
As part of the methodological work that is needed to
addresses the challenges of developing international
guidelines, specific attention should be given to the devel-
opment of standard templates that provide decision mak-
ers with the relevant global evidence that is needed to
inform a decision and offers practical methods for incor-
porating the context specific evidence and judgements
that are needed [40,41].
In addition to ensuring that standard formats are used for
WHO guidelines to ensure complete reporting, attention
should be paid to ensuring that the format that is used,
and derivative versions, are understandable and useful to
the intended target audiences.
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